William Spencer Lewis, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lewis’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G62557 · Current
Licensed to practise in California · since 1988 · expires 2027-11-30 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$162,765
Medicare paid this office $162,765 for 731 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 217 | $30,711 | $115 |
| Short return visit (20+ min) | 249 | $28,509 | $83 |
| New patient visit (45+ min) | 158 | $22,116 | $140 |
| Removal of impacted ear wax | 403 | $21,867 | $41 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $12,293 | $128 |
See all 13 services
| Return visit (30+ min) | 217 | $30,711 | $115 |
| Short return visit (20+ min) | 249 | $28,509 | $83 |
| New patient visit (45+ min) | 158 | $22,116 | $140 |
| Removal of impacted ear wax | 403 | $21,867 | $41 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $12,293 | $128 |
| Diagnostic exam of nasal passages using an endoscope | 50 | $11,224 | $194 |
| New patient visit (30+ min) | 84 | $7,956 | $95 |
| Short return visit | 75 | $4,582 | $54 |
| Simple control of nose bleed | 13 | $3,221 | $170 |
| Long return visit (40+ min) | 17 | $2,918 | $172 |
| Exam of ear using a microscope | 29 | $1,320 | $30 |
| Repositioning exercises of head for treatment of dizziness, each day | 30 | $1,178 | $37 |
| New patient visit (15+ min) | 11 | $641 | $58 |
Who their Medicare patients are
731 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 21% · Women 59% · Also on Medicaid 12% · Health risk score 1.21. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 70% · Coronary heart disease 30% · Diabetes 26% · Cancer 21% · Chronic kidney disease 18% · Atrial fibrillation 17% · Depression 16% · Heart failure 11% · COPD 11% · Stroke 9% · Dementia 7%.
The office billed $854,880, Medicare allowed $217,600 and paid $162,765; for 2,145 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 731 | 2,145 | 77 | 1.21 | $854,880 | $162,765 |
| 2023 | 671 | 1,850 | 78 | 1.12 | $1,080,789 | $162,844 |
| 2022 | 649 | 1,880 | 78 | 1.15 | $711,429 | $155,843 |
| 2021 | 637 | 1,968 | 78 | 1.09 | $709,132 | $163,735 |
| 2020 | 541 | 1,624 | 77 | 1.19 | $590,005 | $114,149 |
| 2019 | 629 | 1,876 | 78 | 1.16 | $785,560 | $162,295 |
| 2018 | 666 | 2,053 | 78 | 1.08 | $516,743 | $149,963 |
| 2017 | 639 | 2,382 | 78 | 1.09 | $234,871 | $159,733 |
| 2016 | 669 | 2,341 | 78 | 1.19 | $222,385 | $148,533 |
| 2015 | 668 | 2,163 | 78 | 1.12 | $210,666 | $137,710 |
| 2014 | 663 | 1,997 | 78 | 1.01 | $201,374 | $137,778 |
| 2013 | 640 | 2,304 | 78 | 1.02 | $215,728 | $142,172 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| New patient visit (45+ min) | 178 | $26,083 | $147 |
| Return visit (30+ min) | 162 | $25,382 | $115 |
| Short return visit (20+ min) | 222 | $25,187 | $80 |
| Removal of impacted ear wax | 333 | $18,509 | $40 |
| Diagnostic exam of nasal passages using an endoscope | 59 | $13,855 | $187 |
| Diagnostic exam of voice box using a flexible endoscope | 80 | $11,023 | $122 |
| New patient visit (30+ min) | 109 | $10,109 | $93 |
| Short return visit | 61 | $3,456 | $50 |
| Long return visit (40+ min) | 18 | $3,106 | $163 |
| Simple control of nose bleed | 17 | $2,739 | $137 |
| Repositioning exercises of head for treatment of dizziness, each day | 26 | $1,272 | $41 |
| Exam of ear using a microscope | 32 | $1,135 | $27 |
| Ct scan of face without contrast | 11 | $1,125 | $102 |
| New patient visit (15+ min) | 14 | $959 | $68 |
2022: 14 services
| Short return visit (20+ min) | 237 | $27,124 | $81 |
| Return visit (30+ min) | 151 | $22,148 | $117 |
| New patient visit (45+ min) | 140 | $19,978 | $143 |
| Removal of impacted ear wax | 320 | $16,850 | $39 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | $11,781 | $123 |
| New patient visit (30+ min) | 88 | $8,697 | $99 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $8,072 | $172 |
| Short return visit | 119 | $6,104 | $42 |
| Long return visit (40+ min) | 21 | $4,148 | $166 |
| Simple control of nose bleed | 18 | $3,760 | $157 |
| Ct scan of face without contrast | 22 | $3,117 | $136 |
| Exam of ear using a microscope | 50 | $2,152 | $29 |
| New patient visit (15+ min) | 19 | $981 | $52 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $827 | $41 |
2021: 15 services
| Return visit (30+ min) | 183 | $29,520 | $122 |
| Short return visit (20+ min) | 204 | $22,065 | $84 |
| Removal of impacted ear wax | 321 | $16,857 | $39 |
| New patient visit (45+ min) | 104 | $16,193 | $156 |
| Diagnostic exam of voice box using a flexible endoscope | 79 | $12,238 | $122 |
| Short return visit | 163 | $11,449 | $50 |
| New patient visit (30+ min) | 105 | $10,837 | $103 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $6,781 | $194 |
| Injection of medication into nasal air passage | 12 | $3,471 | $99 |
| Long return visit (40+ min) | 19 | $3,350 | $160 |
| Ct scan of face without contrast | 18 | $2,843 | $150 |
| New patient visit (15+ min) | 35 | $2,203 | $63 |
| Exam of ear using a microscope | 44 | $2,045 | $28 |
| Repositioning exercises of head for treatment of dizziness, each day | 28 | $1,289 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $58 | None |
2020: 13 services
| Short return visit (20+ min) | 231 | $24,163 | $68 |
| Return visit (30+ min) | 122 | $15,572 | $99 |
| Removal of impacted ear wax | 268 | $13,281 | $38 |
| New patient visit (30+ min) | 125 | $12,410 | $99 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $8,431 | $114 |
| New patient visit (45+ min) | 35 | $5,179 | $148 |
| Diagnostic exam of nasal passages using an endoscope | 17 | $3,402 | $179 |
| Short return visit | 66 | $3,369 | $44 |
| Exam of ear using a microscope | 37 | $2,091 | $27 |
| Ct scan of face without contrast | 15 | $1,957 | $130 |
| Simple control of nose bleed | 12 | $1,748 | $134 |
| New patient visit (15+ min) | 14 | $911 | $65 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $821 | $39 |
2019: 16 services
| Return visit (30+ min) | 222 | $33,883 | $101 |
| Short return visit (20+ min) | 217 | $23,427 | $70 |
| Removal of impacted ear wax | 296 | $15,972 | $41 |
| New patient visit (30+ min) | 136 | $13,788 | $101 |
| Diagnostic exam of nasal passages using an endoscope | 37 | $11,063 | $209 |
| Diagnostic exam of voice box using a flexible endoscope | 74 | $10,781 | $115 |
| New patient visit (45+ min) | 65 | $9,798 | $151 |
| Ct scan of face without contrast | 27 | $4,002 | $143 |
| Simple control of nose bleed | 20 | $3,362 | $129 |
| Short return visit | 62 | $2,946 | $45 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 11 | $2,902 | $264 |
| Exam of ear using a microscope | 39 | $2,147 | $29 |
| Simple removal of skin debris and drainage of mastoid cavity | 11 | $1,936 | $74 |
| New patient visit (15+ min) | 18 | $1,233 | $69 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $877 | $40 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $326 | $23 |
2018: 17 services
| Return visit (30+ min) | 201 | $29,569 | $95 |
| Short return visit (20+ min) | 254 | $23,007 | $58 |
| New patient visit (45+ min) | 132 | $19,176 | $145 |
| Removal of impacted ear wax | 214 | $11,221 | $43 |
| New patient visit (30+ min) | 103 | $9,276 | $90 |
| Diagnostic exam of voice box using a flexible endoscope | 73 | $8,728 | $106 |
| Ct scan of face without contrast | 46 | $6,578 | $134 |
| Diagnostic exam of nasal passages using an endoscope | 20 | $5,875 | $210 |
| Comprehensive hearing and speech recognition test | 109 | $3,121 | $27 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 101 | $2,603 | $25 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 11 | $2,581 | $215 |
| Exam of ear using a microscope | 53 | $2,494 | $25 |
| Simple control of nose bleed | 17 | $2,114 | $106 |
| New patient visit (15+ min) | 23 | $1,498 | $65 |
| Test to assess middle ear function | 110 | $1,269 | $11 |
| Short return visit | 26 | $1,141 | $41 |
| Repositioning exercises of head for treatment of dizziness, each day | 19 | $798 | $40 |
2017: 16 services
| Return visit (30+ min) | 218 | $29,489 | $95 |
| Short return visit (20+ min) | 224 | $22,772 | $61 |
| New patient visit (45+ min) | 114 | $15,625 | $137 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $10,146 | $211 |
| Diagnostic exam of voice box using a flexible endoscope | 77 | $9,744 | $109 |
| New patient visit (30+ min) | 107 | $9,258 | $87 |
| Comprehensive hearing and speech recognition test | 241 | $8,056 | $30 |
| Removal of impacted ear wax | 140 | $7,136 | $39 |
| Ct scan of face without contrast | 48 | $7,073 | $139 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 223 | $6,826 | $27 |
| Exam of ear using a microscope | 72 | $3,079 | $27 |
| Test to assess middle ear function | 223 | $3,027 | $12 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 11 | $2,564 | $214 |
| Simple control of nose bleed | 17 | $1,310 | $77 |
| New patient visit (15+ min) | 16 | $1,067 | $67 |
| Repositioning exercises of head for treatment of dizziness, each day | 19 | $683 | $36 |
2016: 16 services
| Short return visit (20+ min) | 253 | $23,853 | $61 |
| Return visit (30+ min) | 156 | $20,373 | $95 |
| New patient visit (45+ min) | 83 | $11,739 | $141 |
| New patient visit (30+ min) | 131 | $11,333 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $8,883 | $110 |
| Comprehensive hearing and speech recognition test | 234 | $8,042 | $31 |
| Removal of impacted ear wax | 150 | $6,872 | $36 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $6,672 | $202 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 195 | $6,150 | $29 |
| Ct scan of face without contrast | 36 | $5,731 | $140 |
| Test to assess middle ear function | 231 | $3,245 | $13 |
| Simple control of nose bleed | 23 | $3,021 | $86 |
| New patient visit (15+ min) | 28 | $1,520 | $54 |
| Short return visit | 45 | $1,347 | $28 |
| Exam of ear using a microscope | 32 | $1,158 | $29 |
| Repositioning exercises of head for treatment of dizziness, each day | 25 | $1,030 | $40 |
2015: 18 services
| Short return visit (20+ min) | 247 | $22,552 | $61 |
| Return visit (30+ min) | 116 | $13,709 | $91 |
| New patient visit (30+ min) | 149 | $13,418 | $90 |
| Removal of impacted ear wax | 171 | $9,766 | $42 |
| Comprehensive hearing and speech recognition test | 257 | $8,509 | $30 |
| Diagnostic exam of voice box using a flexible endoscope | 58 | $7,525 | $107 |
| New patient visit (45+ min) | 45 | $6,314 | $140 |
| Ct scan of face without contrast | 40 | $5,811 | $138 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $4,958 | $207 |
| Placement of ear probe for computerized measurement of repeated sounds with interpretation and report | 143 | $4,478 | $30 |
| Short return visit | 92 | $4,259 | $36 |
| Test to assess middle ear function | 249 | $3,299 | $12 |
| Simple removal of skin debris and drainage of mastoid cavity | 14 | $2,886 | $137 |
| New patient visit (15+ min) | 43 | $2,695 | $63 |
| Removal of foreign body in ear canal | 13 | $1,397 | $107 |
| Simple control of nose bleed | 12 | $996 | $77 |
| Exam of ear using a microscope | 23 | $754 | $28 |
| Repositioning exercises of head for treatment of dizziness, each day | 13 | $463 | $36 |
2014: 16 services
| Short return visit (20+ min) | 252 | $23,224 | $60 |
| New patient visit (30+ min) | 154 | $14,159 | $92 |
| Return visit (30+ min) | 109 | $12,667 | $99 |
| Ct scan of face without contrast | 50 | $10,615 | $183 |
| Removal of impacted ear wax | 202 | $10,331 | $41 |
| New patient visit (45+ min) | 60 | $8,739 | $146 |
| Diagnostic exam of voice box using a flexible endoscope | 60 | $8,373 | $107 |
| Diagnostic exam of nasal passages using an endoscope | 21 | $6,856 | $208 |
| Short return visit | 139 | $6,657 | $36 |
| Comprehensive hearing and speech recognition test | 157 | $5,314 | $31 |
| New patient visit (15+ min) | 46 | $2,997 | $65 |
| Simple removal of skin debris and drainage of mastoid cavity | 14 | $2,988 | $136 |
| Exam of ear using a microscope | 55 | $2,120 | $24 |
| Test to assess middle ear function | 152 | $2,047 | $13 |
| Simple control of nose bleed | 12 | $925 | $71 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $912 | $38 |
2013: 17 services
| Short return visit (20+ min) | 268 | $25,103 | $61 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $11,760 | $218 |
| Removal of impacted ear wax | 212 | $11,238 | $44 |
| Diagnostic exam of voice box using a flexible endoscope | 76 | $10,214 | $112 |
| Short return visit | 180 | $9,739 | $39 |
| New patient visit (30+ min) | 103 | $9,156 | $89 |
| Comprehensive hearing and speech recognition test | 234 | $7,936 | $32 |
| New patient visit (45+ min) | 40 | $5,925 | $148 |
| Ct scan of face without contrast | 22 | $5,349 | $223 |
| Return visit (30+ min) | 53 | $5,275 | $93 |
| Exam of ear using a microscope | 67 | $2,996 | $29 |
| Test to assess middle ear function | 224 | $2,966 | $13 |
| Simple removal of skin debris and drainage of mastoid cavity | 11 | $2,722 | $130 |
| New patient visit (15+ min) | 39 | $2,500 | $64 |
| Simple control of nose bleed | 18 | $1,895 | $82 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 16 | $630 | $39 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $625 | $39 |
Drugs they prescribed that Part D paid
$15,368
Pharmacies billed $15,368 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
537 generic and 27 brand-name prescriptions · $15,368 in drug cost · 61 antibiotic prescriptions to 48 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Fluticasone Propionate | 119 | $2,645 | $22 |
| Ciprofloxacin-Dexamethasone | 22 | $2,265 | $103 |
| Azelastine | 39 | $2,181 | $56 |
| Ipratropium | 40 | $1,873 | $47 |
| Fluocinolone Acetonide Oil | 38 | $1,417 | $37 |
See all 14 drugs
| Fluticasone Propionate | 119 | $2,645 | $22 |
| Ciprofloxacin-Dexamethasone | 22 | $2,265 | $103 |
| Azelastine | 39 | $2,181 | $56 |
| Ipratropium | 40 | $1,873 | $47 |
| Fluocinolone Acetonide Oil | 38 | $1,417 | $37 |
| Neomycin-Polymyxin-Hc | 22 | $1,203 | $55 |
| Omeprazole | 36 | $711 | $20 |
| Ofloxacin | 16 | $492 | $31 |
| Famotidine | 21 | $222 | $11 |
| Amoxicillin-Clavulanate Potass | 20 | $195 | $10 |
| Prednisone | 28 | $122 | $4 |
| Doxycycline Hyclate | 13 | $119 | $9 |
| Mupirocin | 19 | $105 | $6 |
| Mometasone Furoate | 13 | $76 | $6 |
Year by year
| 2024 | 564 | 262 | None | 5% | $15,368 |
| 2023 | 590 | 236 | 3% (18) | 3% | $19,667 |
| 2022 | 633 | 218 | 3% (21) | 2% | $18,630 |
| 2021 | 698 | 241 | 3% (22) | 2% | $19,445 |
| 2020 | 674 | 220 | 3% (19) | 4% | $28,319 |
| 2019 | 746 | 235 | 3% (21) | 6% | $31,915 |
| 2018 | 660 | 228 | None | 6% | $22,344 |
| 2017 | 674 | 214 | None | 8% | $24,004 |
| 2016 | 725 | 204 | None | 8% | $25,834 |
| 2015 | 596 | 175 | None | 13% | $24,041 |
| 2014 | 587 | 196 | None | 14% | $26,152 |
| 2013 | 572 | 183 | None | 26% | $36,648 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Fluticasone Propionate | 122 | $3,590 | $29 |
| Azelastine | 25 | $2,387 | $95 |
| Fluocinolone Acetonide Oil | 32 | $1,913 | $60 |
| Ipratropium | 56 | $1,700 | $30 |
| Neomycin-Polymyxin-Hc | 29 | $1,592 | $55 |
| Ofloxacin | 14 | $739 | $53 |
| Omeprazole | 33 | $519 | $16 |
| Montelukast | 21 | $372 | $18 |
| Hydrocodone-Acetaminophen | 18 | $217 | $12 |
| Prednisone | 32 | $216 | $7 |
| Amoxicillin-Clavulanate Potass | 14 | $211 | $15 |
| Doxycycline Hyclate | 14 | $205 | $15 |
2022: 17 drugs
| Fluticasone Propionate | 155 | $3,467 | $22 |
| Azelastine | 41 | $2,731 | $67 |
| Ipratropium | 50 | $2,370 | $47 |
| Fluocinolone Acetonide Oil | 25 | $1,634 | $65 |
| Mometasone Furoate | 15 | $957 | $64 |
| Omeprazole | 44 | $785 | $18 |
| Neomycin-Polymyxin-Hc | 11 | $706 | $64 |
| Hydrocodone-Acetaminophen | 17 | $344 | $20 |
| Pantoprazole | 14 | $337 | $24 |
| Triamterene-Hydrochlorothiazid | 19 | $316 | $17 |
| Doxycycline Hyclate | 16 | $272 | $17 |
| Amoxicillin-Clavulanate Potass | 22 | $262 | $12 |
| Ciprofloxacin | 17 | $251 | $15 |
| Montelukast | 21 | $200 | $10 |
| Prednisone | 26 | $158 | $6 |
| Mupirocin | 11 | $121 | $11 |
| Alprazolam | 12 | $44 | $4 |
2021: 17 drugs
| Azelastine | 70 | $2,892 | $41 |
| Ciprofloxacin-Dexamethasone | 15 | $2,523 | $168 |
| Fluticasone Propionate | 149 | $2,509 | $17 |
| Ipratropium | 45 | $2,328 | $52 |
| Omeprazole | 99 | $1,847 | $19 |
| Fluocinolone Acetonide Oil | 21 | $1,208 | $58 |
| Mometasone Furoate | 15 | $831 | $55 |
| Neomycin-Polymyxin-Hc | 16 | $817 | $51 |
| Montelukast | 19 | $307 | $16 |
| Famotidine | 22 | $301 | $14 |
| Ciprofloxacin | 19 | $284 | $15 |
| Triamterene-Hydrochlorothiazid | 11 | $219 | $20 |
| Hydrocodone-Acetaminophen | 18 | $215 | $12 |
| Amoxicillin-Clavulanate Potass | 18 | $197 | $11 |
| Pantoprazole | 11 | $173 | $16 |
| Prednisone | 29 | $158 | $5 |
| Alprazolam | 15 | $71 | $5 |
2020: 15 drugs
| Fluticasone Propionate | 120 | $3,327 | $28 |
| Ipratropium | 40 | $3,104 | $78 |
| Azelastine | 45 | $2,459 | $55 |
| Omeprazole | 92 | $1,852 | $20 |
| Mometasone Furoate | 22 | $1,744 | $79 |
| Fluocinolone Acetonide Oil | 19 | $1,224 | $64 |
| Neomycin-Polymyxin-Hc | 21 | $1,198 | $57 |
| Amoxicillin-Clavulanate Potass | 28 | $366 | $13 |
| Montelukast | 32 | $351 | $11 |
| Triamterene-Hydrochlorothiazid | 14 | $280 | $20 |
| Famotidine | 13 | $214 | $16 |
| Hydrocodone-Acetaminophen | 17 | $201 | $12 |
| Prednisone | 31 | $149 | $5 |
| Ciprofloxacin | 14 | $117 | $8 |
| Alprazolam | 12 | $56 | $5 |
2019: 19 drugs
| Ciprodex | 19 | $4,513 | $238 |
| Fluticasone Propionate | 148 | $2,617 | $18 |
| Omeprazole | 97 | $2,523 | $26 |
| Azelastine | 48 | $2,312 | $48 |
| Fluocinolone Acetonide Oil | 21 | $1,862 | $89 |
| Ipratropium | 28 | $1,321 | $47 |
| Neomycin-Polymyxin-Hc | 16 | $1,026 | $64 |
| Mometasone Furoate | 12 | $677 | $56 |
| Amoxicillin-Clavulanate Potass | 25 | $376 | $15 |
| Prednisone | 51 | $345 | $7 |
| Triamterene-Hydrochlorothiazid | 17 | $334 | $20 |
| Ranitidine | 12 | $305 | $25 |
| Montelukast | 27 | $267 | $10 |
| Ciprofloxacin | 20 | $233 | $12 |
| Hydrocodone-Acetaminophen | 21 | $196 | $9 |
| Cephalexin | 15 | $132 | $9 |
| Levofloxacin | 12 | $94 | $8 |
| Alprazolam | 13 | $89 | $7 |
| Hydrochlorothiazide | 11 | $23 | $2 |
2018: 19 drugs
| Ciprodex | 14 | $3,233 | $231 |
| Fluocinolone Acetonide Oil | 22 | $2,278 | $104 |
| Fluticasone Propionate | 126 | $1,974 | $16 |
| Omeprazole | 95 | $1,889 | $20 |
| Mometasone Furoate | 25 | $1,348 | $54 |
| Azelastine | 40 | $1,276 | $32 |
| Neomycin-Polymyxin-Hc | 13 | $659 | $51 |
| Clotrimazole | 11 | $556 | $51 |
| Cefuroxime | 18 | $545 | $30 |
| Montelukast | 26 | $337 | $13 |
| Mupirocin | 11 | $328 | $30 |
| Amoxicillin-Clavulanate Potass | 23 | $311 | $14 |
| Ranitidine | 19 | $308 | $16 |
| Prednisone | 41 | $279 | $7 |
| Triamterene-Hydrochlorothiazid | 19 | $270 | $14 |
| Alprazolam | 14 | $194 | $14 |
| Levofloxacin | 19 | $171 | $9 |
| Ciprofloxacin | 14 | $130 | $9 |
| Hydrochlorothiazide | 13 | $11 | $1 |
2017: 16 drugs
| Dexilant | 20 | $6,748 | $337 |
| Ciprodex | 21 | $4,231 | $201 |
| Fluticasone Propionate | 127 | $2,024 | $16 |
| Omeprazole | 134 | $1,829 | $14 |
| Fluocinolone Acetonide Oil | 11 | $1,588 | $144 |
| Mometasone Furoate | 11 | $803 | $73 |
| Azelastine | 20 | $787 | $39 |
| Triamterene-Hydrochlorothiazid | 28 | $451 | $16 |
| Ranitidine | 28 | $333 | $12 |
| Amoxicillin-Clavulanate Potass | 28 | $322 | $11 |
| Montelukast | 29 | $259 | $9 |
| Prednisone | 41 | $258 | $6 |
| Alprazolam | 16 | $187 | $12 |
| Levofloxacin | 14 | $187 | $13 |
| Ciprofloxacin | 19 | $160 | $8 |
| Hydrochlorothiazide | 11 | $8 | $1 |
2016: 15 drugs
| Dexilant | 15 | $6,007 | $400 |
| Ciprodex | 20 | $3,767 | $188 |
| Omeprazole | 168 | $2,178 | $13 |
| Fluocinolone Acetonide Oil | 13 | $1,924 | $148 |
| Fluticasone Propionate | 127 | $1,588 | $13 |
| Azelastine | 35 | $1,433 | $41 |
| Triamterene-Hydrochlorothiazid | 37 | $566 | $15 |
| Montelukast | 28 | $298 | $11 |
| Ranitidine | 25 | $281 | $11 |
| Amoxicillin-Clavulanate Potass | 19 | $276 | $15 |
| Ciprofloxacin | 20 | $201 | $10 |
| Alprazolam | 19 | $177 | $9 |
| Potassium Chloride | 11 | $166 | $15 |
| Prednisone | 28 | $163 | $6 |
| Hydrochlorothiazide | 12 | $19 | $2 |
2015: 14 drugs
| Dexilant | 16 | $5,075 | $317 |
| Ciprodex | 25 | $4,304 | $172 |
| Nasonex | 15 | $3,460 | $231 |
| Omeprazole | 141 | $1,964 | $14 |
| Fluticasone Propionate | 119 | $1,087 | $9 |
| Azelastine | 12 | $564 | $47 |
| Ipratropium | 13 | $519 | $40 |
| Triamterene-Hydrochlorothiazid | 26 | $354 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $222 | $15 |
| Ciprofloxacin | 24 | $165 | $7 |
| Potassium Chloride | 13 | $151 | $12 |
| Alprazolam | 27 | $151 | $6 |
| Prednisone | 14 | $131 | $9 |
| Hydrochlorothiazide | 13 | $26 | $2 |
2014: 15 drugs
| Dexilant | 18 | $4,362 | $242 |
| Ciprodex | 19 | $2,982 | $157 |
| Nasonex | 15 | $2,781 | $185 |
| Omeprazole | 130 | $2,019 | $16 |
| Fluocinolone Acetonide Oil | 12 | $1,990 | $166 |
| Fluticasone Propionate | 123 | $1,824 | $15 |
| Azelastine | 13 | $1,133 | $87 |
| Montelukast | 18 | $1,130 | $63 |
| Ipratropium | 25 | $935 | $37 |
| Triamterene-Hydrochlorothiazid | 36 | $418 | $12 |
| Amox Tr-Potassium Clavulanate | 16 | $334 | $21 |
| Potassium Chloride | 12 | $226 | $19 |
| Prednisone | 23 | $178 | $8 |
| Ciprofloxacin | 13 | $109 | $8 |
| Diazepam | 11 | $31 | $3 |
2013: 9 drugs
| Nasonex | 35 | $5,817 | $166 |
| Ciprodex | 22 | $3,271 | $149 |
| Dexilant | 15 | $2,854 | $190 |
| Omeprazole | 108 | $2,638 | $24 |
| Fluticasone Propionate | 106 | $2,468 | $23 |
| Amox Tr-Potassium Clavulanate | 36 | $901 | $25 |
| Ipratropium | 29 | $674 | $23 |
| Triamterene-Hctz | 21 | $313 | $15 |
| Prednisone | 17 | $75 | $4 |
Money from drug and device companies
$23 in 2021
| 2021 | 1 | 1 | None | $23 |
| 2020 | 1 | 3 | None | $70 |
| 2019 | 3 | 5 | None | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Optinose US | Xhance | $23 | 1 payment
|
See the published payment
| Optinose US | Meals · 2021-02-16 | Xhance | $23 |
See earlier years (2020, 2019)
2020: $70
| OptiNose US | Xhance | $70 | 3 payments
|
2019: $104
| OptiNose US | Xhance | $42 | 2 payments
|
| Smith+Nephew | Coblation - Turbinate Wands | $37 | 2 payments
|
| Intersect ENT | Propel | $25 | 1 payment
|
Professional record
- NPI
- 1871585059
- Licence
- CA G62557California G62557: Current · expires 2027-11-30
- Trained
- University of Southern California Keck School of Medicine, 1986
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G625571
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 15861 Winchester Blvd, Los Gatos, CA, 95030
- NPI first listed
- 2005-08-16
- NPI last updated
- 2024-04-29
- NPI record certified
- 2024-04-29
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305